Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

A secondary analysis of a phase 3 trial suggests that patients with relapse within 3 months of treatment or persistent disease represent a distinct high-risk group.

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

* Irregular sleep patterns nearly double the risk of depression relapse * Wearable devices can detect relapse risk weeks or months before symptoms //appear * Less difference between daytime activity ...

Breast cancer treatment has improved greatly over the years, and many patients now survive and live long lives after ...